DOI: 10.1055/s-00000031

Klinische Monatsblätter für Augenheilkunde

References

Hutton DW, Stein JD, Glassman AR. et al.
Five-year cost-effectiveness of intravitreous ranibizumab therapy vs. panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial.

JAMA Ophthalmol 2019;
24: 1-9
doi:10.1001/jamaophthalmol.2019.4284

Download Bibliographical Data

Search in: